Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

Jessica Slostad, Patrick Hoversten, Candace L. Haddox, Kamila Cisak, Jonas Paludo, Ayalew Tefferi

Research output: Contribution to journal › Letter › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience'. Together they form a unique fingerprint.